Improving cervical cancer prevention in Kenya through a single-visit treatment approach
Towards Cervical cancer elimination: Implementation and scale-up of a single-visit, screen-and-treat approach with thermal ablation for sustainable cervical cancer prevention services in Kenya
This study is testing a quick and easy way to help women in Kenya get screened and treated for cervical cancer all in one visit, making it simpler for them to take care of their health and reduce the risk of cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10906824 on NIH RePORTER |
What this research studies
This research focuses on implementing a single-visit, screen-and-treat approach for cervical cancer prevention in Kenya. It utilizes visual inspection with acetic acid and thermal ablation to manage precancerous lesions effectively. The goal is to increase screening uptake and treatment rates among women, addressing logistical challenges in low-resource settings. By adapting and scaling up this method, the research aims to reduce the burden of cervical cancer in Eastern Africa significantly.
Who could benefit from this research
Good fit: Ideal candidates for this research are women aged 30-49 in Kenya who are at risk for cervical cancer.
Not a fit: Patients outside the target age range or those not residing in Kenya may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a substantial decrease in cervical cancer incidence and mortality among women in Kenya.
How similar studies have performed: Previous research has shown that similar screen-and-treat approaches have been effective in reducing cervical cancer rates in other low- and middle-income countries.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Mugo, Nelly Rwamba — University of Washington
- Study coordinator: Mugo, Nelly Rwamba
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.